Skip to content

Drug interactions

Maprotiline + Rilpivirine

Severity: Moderate

Maprotiline and Rilpivirine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rilpivirine at supratherapeutic doses prolongs the QT interval, and maprotiline can also prolong QTc. Combined use may increase the risk of torsades de pointes, especially with electrolyte disturbances or heart disease.

What this interaction means in plain words

Maprotiline and Rilpivirine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Maprotiline belongs to Central Nervous System; Rilpivirine belongs to Anti Virals.

Evidence level: Low

Why it happens

Additive prolongation of cardiac repolarization.

What to do

Obtain a baseline ECG and monitor QTc and electrolytes, correcting hypokalemia and hypomagnesemia. Consider an alternative antidepressant in patients with other QT risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maprotiline and Rilpivirine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maprotiline with Rilpivirine?

MediHelp rates the interaction as moderate. Maprotiline and Rilpivirine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rilpivirine at supratherapeutic doses prolongs the QT interval, and maprotiline can also prolong QTc. Combined use may increase the risk of torsades de pointes, especially with electrolyte disturbances or heart disease.

How serious is the interaction between Maprotiline and Rilpivirine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor QTc and electrolytes, correcting hypokalemia and hypomagnesemia. Consider an alternative antidepressant in patients with other QT risk factors.

What other medicines interact with Maprotiline?

MediHelp also lists interactions of Maprotiline with, for example, Arsenic trioxide, Disopyramide, Dofetilide. The full list is on the Maprotiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in